|
Reliance Industries Limited
|
|
POLYPROPYLENE
|
| REPOL
B030MG |
IMPACT
COPOLYMER |
|
| |
| Product
description & applications : |
Features
: |
|
REPOL Polypropylene B030MG is manufactured using Unipol
PP process which combines the production efficiency
of gas phase fluidized bed reactor technology with the
high activity and stereo specificity of the SHAC catalyst
system.
REPOL B030MG is recommended for use in Injection Moulding
Process. It is an ideal material for use in appliances,
crates, furniture, textile and automobile components
where medium impact strength is required.
|
Repol
B030MG is designed to provide
- Consistent processablitity
- Good Stiffness-impact balance
- Good surface
|
| |
| Typical properties
of Repol B030MG are as follows: |
| |
| Property |
ASTM Test Method |
Unit |
Typical Value*. |
| Melt flow index,(230oc/2.16Kg) |
D 1238 |
g/10 min |
3.0 |
| Tensile Strength at yield
(50 mm/min ) |
D 638$ |
MPa |
26.5 |
| Elongation at yield (50
mm/min ) |
D 638$ |
% |
10 |
| Flexural modulus (1% secant) |
D 790A$ |
MPa |
1200 |
| Notched izod impact strength
(23oc) |
D 256$ |
J/m |
110 |
| Heat deflection temperature
(455 kPa) |
D 648 |
oC |
95 |
| |
| |
|
$ : ASTM D638 Type I specimen injection moulded and
tested in accordance with ASTM D4101.
|
|
|
|
Repol B030MG meets the requirements stipulated in IS
10910-1984 on on "Specification for Polypropylene and
its copolymers for safe use in contact with foodstuffs,
pharmaceuticals, and drinking water". Additives incorporated
in this grade conform to the positive list of constituents
as prescribed in IS-10909-1984.The grade and the additives
incorporated in it also comply with the FDA:CFR Title
21, 177.1520, Olefin polymers.
|
|
|
|
REPOL is the registered trademark for Polypropylene
from Reliance Industries Limited
|
|
|
|
* Typical valuesw with injection moulded specimens,
not to be taken as specification
|
|
The data, information and suggestions contained contained
herein are given purely as a guide. Reliance Industries
Limited and Reliance Group Companies undertake no responsibility
either for the results deriving from their adoption
or for possible position in apparent contrast with existing
patent rights.
|